rs199473305
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000423572.7(SCN5A):c.5224G>A(p.Gly1742Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1742E) has been classified as Pathogenic.
Frequency
Consequence
ENST00000423572.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.5227G>A | p.Gly1743Arg | missense_variant | 28/28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.5224G>A | p.Gly1742Arg | missense_variant | 28/28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.5227G>A | p.Gly1743Arg | missense_variant | 28/28 | 5 | NM_001099404.2 | ENSP00000410257 | P4 | |
SCN5A | ENST00000423572.7 | c.5224G>A | p.Gly1742Arg | missense_variant | 28/28 | 1 | NM_000335.5 | ENSP00000398266 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151948Hom.: 0 Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461892Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151948Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74232
ClinVar
Submissions by phenotype
Brugada syndrome 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | KardioGenetik, Herz- und Diabeteszentrum NRW | Nov 11, 2024 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 19, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1743 of the SCN5A protein (p.Gly1743Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Brugada syndrome (PMID: 12639704, 15023552, 22984773, 25904541). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 67967). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN5A function (PMID: 15023552, 23420830). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2024 | Identified in patients with Brugada syndrome referred for genetic testing at GeneDx and in published literature (PMID: 12639704, 15023552, 21147441, 21126620, 20129283, 22840528, 22984773, 25904541, 29203570, 30193851, 30972196, 31737537, 35331424); Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate significantly reduced plasma membrane expression of the Nav1.5 sodium channel and reduced sodium current in vitro (PMID: 23420830, 15023552); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12639704, 28341781, 29203570, 29951135, 23420830, 22840528, 21126620, 20129283, 26111534, 22984773, 28150151, 25904541, 30203441, 15023552, 30662450, 30972196, 33221895, 31737537, 33131149, 35113650, 30193851, 21147441, 35331424, 35231055, 35675436, 35866404, 36435694, 36129056) - |
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 14, 2021 | - - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The p.G1743R pathogenic mutation (also known as c.5227G>A), located in coding exon 27 of the SCN5A gene, results from a G to A substitution at nucleotide position 5227. The glycine at codon 1743 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been reported in multiple subjects with Brugada syndrome and has been shown to segregate with disease (Takahata T et al. Life Sci., 2003 Apr;72:2391-9; Valdivia CR et al. Cardiovasc. Res., 2004 Apr;62:53-62; Hermida JS et al. Am. J. Cardiol., 2010 Dec;106:1758-62; García-Molina E et al. Clin. Genet., 2013 Jun;83:530-8; Kapplinger JD et al. Circ Cardiovasc Genet, 2015 Aug;8:582-95; Yamagata K et al. Circulation, 2017 Jun;135:2255-2270). This alteration has been shown to result in impaired protein trafficking and abolished channel activity (Valdivia CR et al. Cardiovasc. Res., 2004 Apr;62:53-62; Chakrabarti S et al. Circ Arrhythm Electrophysiol, 2013 Apr;6:392-401). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Brugada syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Brugada syndrome in the following publications (PMID:12639704;PMID:15023552;PMID:20129283). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at